Maravai LifeSciences
MRVI
MRVI
210 hedge funds and large institutions have $1.18B invested in Maravai LifeSciences in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 72 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
-13
Holders Change %
-5.83%
% of All Funds
3.04%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
35
Increased
74
Reduced
72
Closed
47
Calls
$3.48M
Puts
$1.81M
Net Calls
+$1.67M
Net Calls Change
+$3.32M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$18.9M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$18.9M |
| 3 |
1WCM
12 West Capital Management
New York
|
+$13.9M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$7.61M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.13M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$27.2M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$19.4M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$17.9M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$10.4M |
| 5 |
EIP
Epoch Investment Partners
New York
|
-$9.56M |
